A/B Test Design & Statistical Rigor Questions

Direct answer

A novelty effect is a temporary inflation of an early treatment effect: users explore or click on something purely because it is new, and that extra engagement fades once the feature stops being novel, biasing an early readout upward. A primacy effect (sometimes called a change-aversion or resistance-to-change effect) is the opposite pattern: a change disrupts a habitual workflow, so users are temporarily worse off while they relearn it, biasing an early readout downward, then the effect climbs toward its true level as users adapt. Both biases fade over roughly the same kind of horizon, so trusting a week-one number without checking its trajectory can make you launch a fad or kill a genuine win too early.

Structured elaboration

Mechanism and direction

Diagnostics to tell a spike from a persistent effect

• Time-windowed effect plot: daily or weekly treatment effect with confidence intervals, ideally with a smoothed trend line (LOESS or a spline), not a single pooled average. A genuine effect looks like a roughly flat band around a nonzero value; novelty looks like a spike that decays toward that band; primacy looks like a trough that rises toward it.
• Exposure-age cohorts, not calendar time: plot the effect against days since each user's first exposure for a fixed cohort of users first exposed on the same day, rather than calendar date. A calendar-time plot mixes newly exposed users (still novel-biased) with long-exposed users (already stabilized) every single day, which can mask a real decay curve as a flat line.
• New vs. returning user split: novelty is usually concentrated in users encountering the feature for the first time; if the effect is similar in a segment already exposed for weeks, that argues against novelty as the explanation.
• Change-point or decay model on the daily series: fit a time-varying effect model, effect as a function of exposure age, and test whether the transient component is statistically distinguishable from zero, separately from the asymptotic (persistent) component.
• Placebo check: run the same time-windowed analysis on a pre-launch period with no real treatment; if spike-like patterns appear there too, the "decay" you see in the real experiment may just be normal week-to-week noise, not a novelty artifact.

Adjusting duration and analysis

• Pre-register the analysis window before launch rather than reading the metric the moment it looks good; a fixed rule such as "primary read is the average effect over exposure-days 21 to 35" prevents cherry-picking the peak or the trough.
• Extend the experiment until the exposure-age curve visibly plateaus, or the fitted transient component's confidence interval crosses zero, rather than for a fixed calendar duration chosen in advance.
• Report both the early-window and late-window effect side by side rather than a single blended number; a launch decision based only on the blended average silently averages a fading spike with a stabilizing floor.

Worked example

Two hypothetical (illustrative, not real study data) weekly average-treatment-effect readings for the same nominal conversion metric:

Both curves are converging toward roughly the same persistent level, one from above and one from below, which is exactly the signature that separates them from a flat, genuine effect that would show roughly the same number every week within noise.

If the transient component decays exponentially, $\Delta(t) = C + A e^{-\lambda t}$, where $A$ is the size of the initial novelty or primacy spike above the persistent effect $C$ (the extra amount present at $t=0$ that fades away over time), and the illustrative decay rate is $\lambda = 0.2$ per week, its half-life is:
$t_{1/2} = \frac{\ln 2}{\lambda} = \frac{0.693}{0.2} \approx 3.5 \text{ weeks}$
That is the kind of number worth pre-registering as a decision rule: run at least three half-lives (about 10 to 11 weeks here) before reading the persistent effect $C$, rather than picking an arbitrary duration.

Trade-offs and pitfalls

• Waiting out a full decay curve costs calendar time and opportunity cost on other experiments; for low-stakes features, teams sometimes accept the risk of a novelty-inflated launch decision rather than run for months.
• Segmenting by exposure age needs per-user first-exposure timestamps captured in the assignment log; if you only log calendar-date rollups, you cannot separate calendar effects from exposure-age effects after the fact.
• A curve that looks like decay can just as easily reflect unrelated seasonality (marketing pushes, holidays) that correlates with launch timing; a decay-shaped curve is suggestive, not conclusive, on its own.
• Don't assume every early spike is novelty and every early trough is resistance to change: an early spike can be a genuine effect solving a pent-up need immediately, and an early trough can be a real bug that later gets patched. The pattern is evidence, not proof, and should be paired with qualitative checks (support tickets, session recordings) before concluding the mechanism.